|
|
 |
| |
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Manufacturing
|
Identity card of the Cooper Pharma manufacturing site in Tit Mellil
|
Date of operation
1980
|
Number of products
159
|
|
Surface
20,000 sq.m. of which 14,000 sq.m. are covered
|
Number of presentations
273
|
|
Nominal capacity
30 million boxes (60 millions in 2 shifts)
|
Sites multifaced
Solids, liquids, pastes and injections
|
|
Production 2009
30 million boxes
|
Certification
Approval BPF ISO 9001v2000
|
|
|
|
Organizational Chart
* Start of construction work in 2009
|
Tit Mellil industrial unit (Cooper Pharma)
|
|
Founded in 1980, the factory occupies an area of 20,000 m2 and has about 300 employees. With a manufacturing capacity of 30 million units per year or 60 million units with 2 shifts, the Tit Mellil unit manufactures injectables, solids, liquids and paste forms. The site is certified ISO 9001 version 2000, GMP and AFSSAPS.
|
|
Bouskoura industrial unit (MC Pharma)
|
|
On this site created in 2007 Cooper Pharma manufactures mostly effervescent tablets according to specific standards and conditions as the use of a dry air system. Production capacity at the site TM Pharma can reach 150 million effervescent tablets.
|
|
Nouaceur industrial unit (C&C)
|
|
Operational in 2011, the plant is totally dedicated to manufacturing anti-cancer drugs according to European (EMEA) and American (US FDA) guidelines.
|
|
New injectables plant
|
In 2009, Cooper Pharma manufactured in its current plant 14 million injectable vials, packed into 2, 2 million boxes.
To respond to the growth of our needs, the injectable manufacturing plant will be launched in 2010 with an effective start of the operations in end 2011.
|
|
|
|
|
|
|
|
| © 2007-2010 Cooper Pharma - Created and maintained by WSI
|
|
|
|
|
|